RichardsonAChapmanKGrahamP, et al.Procalcitonin assay variation in an Australasian external quality assurance program. Ann Clin Biochem2025; 14: 45632251372749.
2.
HuynhHHBœufAPfannkucheJ, et al.Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us?Clin Chem Lab Med2021; 59(10): 1610–1622.
3.
MasettoTEidizadehAPeterC, et al.National external quality assessment and direct method comparison reflect crucial deviations of Procalcitonin measurements in Germany. Clin Chim Acta2022; 529: 67–75.
4.
Assink-de JongEde LangeDWvan OersJA, et al.Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients. BMC Infect Dis2013; 13(1): 178.
5.
KyriazopoulouELiaskou-AntoniouLAdamisG, et al.Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med2021; 203(2): 202–210.
6.
DarkPHossainAMcAuleyDF, et al.Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. JAMA2025; 333(8): 682–693.
7.
SchuetzPBeishuizenABroylesM, et al.Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med2019; 57(9): 1308–1318.
8.
Homer. The Odyssey. Translated by E. V. Rieu. London: Penguin Classics, 1996.
